MAPrc to lead new major depression study
Dr Shainal Nathoo recently attended an investigator meeting in Taipei, Taiwan, for a new major depression study with Otsuka Pharmaceutical. The study will be looking at evaluating the effectiveness of an adjunct treatment option (i.e. new medication is added to the person's existing treatment). The chief investigator is Prof Jayashri Kulkarni and the MAPrc research team includes by Anthony de Castella, Dr Shainal Nathoo, and Mirjana Stojkovic. The trial will commence in May 2014 and will be recruiting participants who have been diagnosed with treatment resistant depression.